| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.03 |